Cedars-Sinai癌症研究中发现的早期胰腺癌发作不准确80%。 80% inaccuracy in early pancreatic cancer staging found in Cedars-Sinai Cancer study.
根据来自48 000多名患者的数据,在日本医学协会的Cedars-Sinai癌症研究表明,大约80%的病例中,早期胰腺癌的发病不准确。 A Cedars-Sinai Cancer study in JAMA reveals that staging for early pancreatic cancer is inaccurate in about 80% of cases, based on data from over 48,000 patients. 这种分类错误可能误导治疗,影响研究资格,特别是未能确定淋巴结的参与。 This misclassification can misguide treatment and affect research eligibility, particularly failing to identify lymph node involvement. 该研究强调,迫切需要改进诊断和筛查技术,以提高患者的结果,因为早期检测会大大提高存活率。 The study highlights the urgent need for improved diagnostic and screening technologies to enhance patient outcomes, as early-stage detection significantly increases survival rates.